|
Match
|
Document |
Document Title |
|
|
5009895 |
Sustained release with high and low viscosity HPMC
Sustained release formulations are disclosed which contain a therapeutically active medicament and a high and low viscosity HPMC and which exhibit a zero order release profile.
|
|
|
5009887 |
Deodorant composition in the form of a gel
A new deodorant composition in the form of gel is now provided, which comprises 2% to 30% by weight of sodium polyacrylate or ammonium polyacrylate having a molecular weight of form 40,000 to...
|
|
|
5008113 |
Method for preparing film coated pharmaceutical preparations and method for improving properties thereof
Film coated pharmaceutical preparations, which are prepared by overlaying to the outer surface of pharmaceutical preparations, a coating layer comprising at least one member selected from the group...
|
|
|
5000962 |
Long acting diltiazem formulation
A long acting diltiazem formulation is disclosed that comprises more than 35 percent by weight of a swellable hydrophilic polymer. Release rate is also controlled by the application of diffusion...
|
|
|
4999226 |
Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
The present invention is directed to a multi-layered tablet containing an ibuprofen layer, a piperidino-alkanol antihistamine layer, and a layer or layers containing conventional pharmaceutical...
|
|
|
4999200 |
Psyllium tablet composition, method of manufacture and method of use
A psyllium composition in tablet form is provided having a wetting agent, a disintegrant and a binding agent. In one embodiment, the wetting agent is polysorbate 80, the binding agent is polyvinyl...
|
|
|
4996061 |
Pharmaceutical composition for piperidinoalkanol-decongestant combination
The present invention relates to a pharmaceutical composition in the form of a multiple-compression tablet comprising (a) a discrete zone made with Formulation (A) which comprises a carrier base...
|
|
|
4983730 |
Water soluble cellulose acetate composition having improved processability and tensile properties
Water soluble cellulose acetate composition having improved processability and tensile properties suitable for application as films, coatings and fibers and comprising one or more lower molecular...
|
|
|
4971805 |
Slow-releasing granules and long acting mixed granules comprising the same
Slow-releasing granules which are characterized by coating the quick-releasing granules which comprise an active ingredient, polyvinyl pyrrolidone polymer and a disintegrator where the polymer...
|
|
|
4970081 |
Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
An aqueous-based formulation for coating aspirin granules to provide granules that may be compressed into tablets and that show approximately zero-order release kinetics for release rates of 5 to...
|
|
|
RE33429 |
Lattice-entrapped emollient-moisturizer composition
This invention relates to solid emollient-moisturizer compositions, and in particular relates to compositions wherein an emollient-moisturizer is entrapped in the lattice of the cross-linked...
|
|
|
4968506 |
Pharmaceutical dosage with core of N-acetyl cystein
The present invention relates to a novel pharmaceutical composition comprising N-acetyl cysteine, wherein the composition releases N-acetyl cysteine in accordance with the United States Pharmacopea...
|
|
|
4968508 |
Sustained release matrix
This invention provides a matrix composition for sustained drug delivery which is comprised of an active agent, a hydrophilic polymer and an enteric polymer. The enteric polymer is impermeable to...
|
|
|
4966772 |
DHP delayed release preparation
A solid medicament preparation having long-lasting action containing a sparingly soluble dihydropyridine active compound of the Formula (I) ##STR1## the preparation having a core-coating...
|
|
|
4959219 |
Coating barriers comprising ethyl cellulose
Coatings for individual ion exchange resin particles comprised of (a) ethylcellulose and (b) corn oil or acetylated monoglycerides.
|
|
|
4957745 |
Pharmaceutical preparation
Controlled release preparation containing a number of beads comprising a salt of metoprolo as the main soluble component, a method for the production thereof and the use in the treatment of...
|
|
|
4954349 |
Oral magnesium and potassium compositions and use
Solid oral composition for the treatment or prophylaxis of potassium and magnesium deficiency in skeletal and cardiac muscle containing about 3 to about 50 milliequivalent bioavailable potassium,...
|
|
|
4948622 |
Method for the preparation of coated solid medicament form
Solid medicament forms, such as granules, beads, tablets, are first coated with a hot aqueous dispersion of a cellulose ether, which is soluble in cold water but insoluble in hot water, and then...
|
|
|
4940587 |
Oral pharmaceutical composition through mucosa
An arrangement is provided for the application of an oral pharmaceutical to the mucosa of the oral or nasal cavity, for sustained release there of the drug. The arrangement of the invention...
|
|
|
4937079 |
Pharmaceutical composition for the prophylaxis and therapy of gastric ulcer
The combination of a hydrophilic polymer with sulglycotide in pharmaceutical compositions for orally use enhances the anti-ulcer activity of sulglycotide.
|
|
|
4933186 |
Dihydropyridine depot formulation
A pharmaceutical formulation tablet with a long-lasting action for 1 to 2 daily doses having a diameter between about 0.5 and 15 mm and comprising (a) a rapid-release core of a dihydropyridine, ...
|
|
|
4931286 |
High gloss cellulose tablet coating
High gloss pharmaceutical tablets have an outer coating of sodium carboxymethylcellulose and polyethylene glycol as 0.1 to 5.0% by weight of the tablet. The sodium carboxymethylcellulose has a D.S....
|
|
|
4919938 |
Sustained release pharmaceutical compositions in oral dosage form
Oral dosage forms for neutral, zwitterions or slats of acidic or basic drugs with approximate zero order release kinetics comprise a core matrix of the drug, and a gelling polymer, the matrix being...
|
|
|
4913906 |
Novel controlled release dosage form of valproic acid
The invention relates to controlled release pharmaceutical compositions. These contain as active ingredient valproic acid, a salt of valproic acid, an ester of valproic acid, Valpromide, or any...
|
|
|
4910022 |
Phthalazineacetic acid composition and tablet
A tablet composition for a phthalazineacetic acid compound to be employed in treating clinical effects associated with diabetes is described. The composition permits formation of tablets having a...
|
|
|
4908214 |
Pharmaceutical tablet for the treatment of uraemia
A tablet constituted by (1) a core comprising a mixture of salts formed by a basic α-amino acids and α-keto analogues of branched-chain essential amino acids and (2) a gastroresistant or...
|
|
|
4897270 |
Pharmaceutical compositions
A pharmaceutical tablet is described which comprises a tablet core containing the antibiotic cefuroxime axetil and a film coat which serves to mask the bitter taste of the cefuroxime axetil upon...
|
|
|
4892741 |
Press coated DHP tablets
The invention relates to solid pharmaceutical preparations which have a long-lasting action and are for dihydropyridines in the form of a press coated tablet, and a process for their preparation.
|
|
|
4892742 |
Controlled release compositions with zero order release
Pharmaceutical compositions for controlled release of water soluble drugs are disclosed. The compositions comprise a tablet core containing the drug and a water insoluble polymeric matrix...
|
|
|
4888179 |
Diuretic composition
The present invention relates to a multiple-unit dose composition comprising furosemide as pharmaceutically active compound, whereby the composition gives a release of furosemide in accordance with...
|
|
|
4880636 |
Film coated tablet of ranitidine HCl
This invention relates to an improved polymeric film coating for a ranitidine Hydrocholride (HCl) tablet in which the plasticizer triacetin had been added to the polymeric film coating medium. A...
|
|
|
4873090 |
Non-adjuvenated vaccine
An enteral non-adjuvenated monobacterial vaccine comprising killed bacteria gives a better protection against acute episodes of infection in patients with long term chronic lung disease than a...
|
|
|
4867987 |
Pharmaceutical product for the sustained release of ibuprofen
The product consists of tablets which contain at least 600 mg of ibuprofen and a binder, or a mixture of binders, based on cellulose and cellulose derivatives in the form of microspheres which are...
|
|
|
4865849 |
Tablet for pharmaceutical use able to release active substances at successive times
A tablet for pharmaceutical use able to release active substances at successive times, comprising at least; a first layer containing a portion of the active substance with suitable excipients, a...
|
|
|
4863743 |
Controlled release potassium chloride
A controlled release potassium chloride tablet is disclosed which is comprised of potassium chloride crystals having a mesh size of about 30 to about 50 mesh which are coated with a coating...
|
|
|
4859471 |
Pancreatic enzyme products and a process for the preparation thereof
A process for the preparation of pancreatic enzyme products in compressed form is described. A water-based insulating layer and a final lacquer based on organic solvents are applied to the core...
|
|
|
4857337 |
Enteric coated aspirin tablets
Enteric coated aspirin tablets rendered shock-insensitive by the provision of a protective coat of hydroxyproply methylcellulose of at least about 1.5% by weight based on the weight of the tablet...
|
|
|
4853230 |
Pharmaceutical formulations of acid labile substances for oral use
Pharmaceutical preparation containing an acid labile compound together with an alkaline reacting compound or an alkaline salt of an acid labile compound optionally together with an alkaline...
|
|
|
4851226 |
Chewable medicament tablet containing means for taste masking
Chewable medicament tablets are made from coated granules of medicament wherein the coating on said granules comprises a blend of cellulose acetate or cellulose acetate butyrate and polyvinyl...
|
|
|
4851233 |
Sustained release formulations
A new drug delivery system, which gives sustained release properties is made by combining certain cellulosic polymers with cellulose in a binder system.
|
|
|
4844907 |
Pharmaceutical composition comprising analgesic and anti-inflammatory agent
A pharmaceutical composition in the form of a multiphase (especially a bilayered, optionally coated) tablet. The tablet has a narcotic analgesic phase containing a therapeutically effective...
|
|
|
4834982 |
Potassium-neutral salureticum with anti-hypertensive effect
A diuretically active combination comprising furosemide and triamterene in a ratio of 1:1 to 1:2, in which furosemide is in the form of controlled release so as to facilitate solubilization of the...
|
|
|
4832956 |
Disintegrating tablet and process for its preparation
A desintegration tablet contains the filler material in a form and/or size which when coming in contact with water at ambient temperature dissolves so slowly that the water absorption and the...
|
|
|
4832952 |
Pharmaceutical composition containing a liquid lubricant
Pharmaceutical compositions produced with liquid, hydrophilic lubricants possessing markedly improved dissolution rates.
|
|
|
4828843 |
Cylindrical microtablets
Cylindrical microtablets which have a convex upper face and a convex lower face and whose cylinder diameter and height independently of one another are each from 1.0 to 2.5 mm and the ratio of the...
|
|
|
4828840 |
Sustained-release formulation and production thereof
Sustained-release formulations which can release a water-soluble active ingredient or ingredients at the zero-order over a long period of time, comprising: a. an inert core, b. a...
|
|
|
4828842 |
Water dispersible compound
The specification discloses a dietary bulking agent comprising psyllium powder, Aspartame™ and a coating of a blend of hydroxypropyl methylcellulose with a minor amount of polyethylene glycol.
|
|
|
4822629 |
Azumolene dosage form
The invention involves a method for achieving systemic administration of azumolene by delivering the drug to the intestines without exposing the drug in the stomach, and pharmaceutical compositions...
|
|
|
4816264 |
Sustained release formulations
Drug delivery systems which exhibit sustained release properties when administered are produced using a "dual control" system which employs polymeric agents in core and membrane portions.
|
|
|
4810502 |
Pseudoephedrine brompheniramine therapy
A dosage form is disclosed for delivering the beneficial drugs pseudoephedrine and brompheniramine to a biological environment of use.
|